Lawsuit Overview
<p>St. Louis-based KV Pharmaceuticals Inc. said on Monday that a settlement was reached. in the shareholders derivative lawsuit. The shareholders derivative lawsuit was filed over KV Pharmaceuticals Inc.’s directors options granting practices. KV Pharmaceuticals Inc. did not disclose the amount of the settlement, but said it expected insurance to cover the fees and costs, and wi...
You must register (for free) or login to view the entire case.